News & Events

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting. Given that taxanes remain the only chemotherapy agents with demonstrated survival...

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though prescription buprenorphine can be a life-saving treatment that relieves opioid cravings and withdrawal symptoms, adherence to the medication is low.

Published March 6 in JAMA Health Forum, the...

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.

Dr. Rohan Jotwani, the Nanette Laitman Education Scholar in Entrepreneurship and an assistant professor of clinical anesthesiology at Weill Cornell Medicine, has been selected for the prestigious Macy Faculty Scholars Program.

One of five educators nationwide to make up the class of 2026, Dr. Jotwani becomes Weill Cornell Medicine’s first-ever Macy Faculty Scholar, and the first anesthesiologist ever to receive...

A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers from Weill Cornell Medicine, Rockefeller University, and collaborating institutions offer a unprecedented look into these hidden HIV‑harboring cells and show that some may be more vulnerable to immune destruction than previously believed.

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators.

In the study, published Feb. 23 in Nature Metabolism, the researchers showed that in fat cells called white adipocytes, high levels of fatty acids from fat stores, in the presence of a key enzyme called AAC, can trigger a process that uses fat to...

In an effort to unify the rapidly expanding set of academic activities investigating artificial intelligence (AI), Weill Cornell Medicine is launching a new AI to Advance Medicine initiative.

Encompassing a Dean’s Lecture Series and Dean’s Grant Program, the initiative aims to provide the institutional infrastructure and services needed to support AI use safely and effectively among faculty, staff and students. Additionally, a new...

In the early aughts, when anesthesiologist Dr. Gunisha Kaur, M.D. ’10, was a medical student at Weill Cornell Medicine, she sought to help immigrants who were seeking refuge in the United States after experiencing persecution or torture in their home countries. It’s a passion drawn from a profoundly personal experience: As a daughter of Indian immigrants and an...

The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. The findings may offer comfort to patients concerned about their eye health while taking the drug.

Diabetic retinopathy develops when chronically high blood sugar damages the blood vessels lining the back of the eye and affects...

When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine. This reconfiguration is crucial to combating infections amid food insecurity.

“Both famine and infectious disease have been with us throughout our evolutionary history and often occurred at the same time. Yet little is known about how nutrition affects the immune system,” said senior author...

Dr. George Coukos, an internationally renowned expert on cancer immunology, is on a mission to rapidly translate tumor biology research into personalized, cell-based therapies for patients with some of the hardest-to-treat cancers. A new laboratory, part of an innovative collaboration between Weill Cornell Medicine and the Ludwig Institute for Cancer Research, seeks to do just that.

Dr. Coukos, who served as the founding director of the Ludwig Lausanne Branch in Switzerland for the...

A new study found that laws temporarily restricting access to firearms for individuals at high risk of harming themselves or others reduced firearm suicides without a shift to other suicide methods, according to researchers at Weill Cornell Medicine and UC Berkeley School of Public Health.

A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer​, according to researchers at Weill Cornell Medicine. This casts the gut microbiome—the trillions of microorganisms living in the intestine—as a central player in the body's response to cancer and to modern cancer treatments like immunotherapies.

Dr. MacKenzi Preston, assistant professor of clinical pediatrics, was awarded the Brause Family Award for Medical Education, Research and Patient Care for her project, “Leveraging Large Language Models to Enhance OSCE Feedback and Competency Tracking.” The award, part of Weill Cornell Medicine’s education scholar awards, supports one faculty member for a targeted project incorporating artificial intelligence...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with inflammatory bowel disease (IBD) have a higher risk of colorectal cancer, according to a preclinical study by Weill Cornell Medicine investigators. The findings point to new possibilities for diagnosis, monitoring and treatment of IBD.

The study began with a focus on TL1A, an inflammatory immune signaling protein known to be...

Weill Cornell Medicine has received a $5.2 million, initial two-year award  from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies (LIGHT) program to develop a comprehensive and innovative approach to diagnosing lymphatic disease. LIGHT is led by ARPA-H Program Manager Kimberley Steele, M.D., Ph.D....

Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine researchers. However, political differences over who is responsible will shape the country’s next phase of drug policy.

Historically, Americans have viewed people who use opioids as primarily responsible for the overdose crisis, with conservatives especially emphasizing...